Keratin, type II cytoskeletal 8
Keratin 8 variant, partial (226-236) is a synthetic peptide fragment derived from the intermediate filament protein keratin 8, specifically encompassing amino acid residues 226 to 236 of the native sequence. As a representative segment of the type II keratin family, this peptide reflects a structurally and functionally significant region that is frequently studied in the context of cytoskeletal organization, epithelial cell biology, and protein-protein interactions. Its defined sequence and partial nature make it a valuable tool for probing the molecular mechanisms underlying keratin filament assembly, post-translational modifications, and the role of keratin variants in cellular stress responses. Researchers utilize such peptide fragments to dissect the biochemical properties of keratin 8, investigate its interaction landscape, and model disease-associated mutations with high precision.
Peptide interaction studies: The 226-236 region of keratin 8 is implicated in mediating specific protein-protein interactions within the cytoskeleton and with regulatory binding partners. Synthetic peptides corresponding to this segment are widely used in binding assays, pull-down experiments, and surface plasmon resonance analyses to map interaction motifs and identify novel keratin-associated proteins. By providing a defined interface, the peptide enables detailed characterization of binding affinities and specificity, facilitating insights into cytoskeletal network regulation and the impact of sequence variations on molecular recognition.
Epitope mapping and antibody validation: The partial peptide sequence spanning residues 226 to 236 serves as a precise epitope for the generation and validation of monoclonal or polyclonal antibodies targeting keratin 8. Researchers employ this fragment in immunoassays, such as ELISA or Western blot, to assess antibody specificity, cross-reactivity, and sensitivity. Such applications are instrumental in developing reliable immunodetection tools for studying keratin expression patterns, cellular localization, and post-translational modifications in diverse epithelial systems.
Phosphorylation and post-translational modification analysis: The selected region of keratin 8 includes sites that are susceptible to phosphorylation and other regulatory modifications. Synthetic peptides mimicking this sequence are used as substrates in kinase assays, facilitating the identification of modification sites and the characterization of upstream regulatory enzymes. These studies contribute to a deeper understanding of how post-translational modifications modulate keratin filament dynamics, signal transduction pathways, and cellular adaptation to stress.
Peptide-based structural studies: The 226-236 peptide fragment provides a tractable model for investigating the secondary structure and conformational properties of keratin 8. By employing spectroscopic techniques such as circular dichroism or nuclear magnetic resonance, researchers can assess the propensity of this sequence to adopt specific structural motifs, such as alpha-helices or beta-strands. Insights gained from such studies inform the broader understanding of intermediate filament assembly, mechanical stability, and the structural consequences of disease-associated mutations within the keratin family.
Cellular uptake and trafficking assays: Labeled derivatives of the keratin 8 (226-236) peptide are utilized to study cellular uptake mechanisms, intracellular trafficking, and peptide stability within epithelial cells. By tracking the fate of fluorescently tagged or biotinylated peptides, investigators can elucidate the pathways involved in peptide internalization, degradation, or incorporation into cytoskeletal structures. These applications support research into peptide-based delivery systems, cellular processing of cytoskeletal fragments, and the influence of sequence context on peptide bioavailability and localization.
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More